Consistent with earlier evidence, overexpression of LILRB2—particularly in concert with its ligand angiopoietin-like protein 2—has been identified as a strong predictor of poor prognosis in CRC (Zhao et al., 2024). The gene discussed is LILRB2; the disease is colorectal carcinoma.